Trump administration proposes altering rule on drug rebates Print E-mail
Written by FHI's Week in Review   
Monday, 23 July 2018 13:47

The Trump administration has proposed a rule that would scale back protections currently in place that allow rebates between drug manufacturers and insurers and pharmacy benefits managers, according to the Office of Management and Budget (OMB) website. Details of the proposed rule have not yet been made public, but its title on the OMB site refers to removing the safe harbor protection for rebates from the anti-kickback law.

Read more in the current issue of Week in Review>>
Last Updated on Friday, 24 August 2018 17:06

Website design, development, and hosting provided by